Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32 Page 33 Page 34 Page 35 Page 36 Page 37 Page 38 Page 39 Page 40 Page 41 Page 42 Page 43 Page 44Data Analysis Biosimilars Individualized Care Data Analysis Data Analysis 33 TUESDAY, SEPTEMBER 19, 2017 Data Analysis TUESDAY, SEPTEMBER 19, 2017 Data Analysis l Data Analysis l Data AnalysisSymposium 16 l 1:30 – 5:30 pm Opioid Abuse & Misuse: A Rising Epidemic in America APPLICATION TRACK Offers both CME and CPE Credit UAN #0238-0000-17-019-L05-P ACPE – 3.5 CONTACT HOURS/APPLICATION-BASED CO-CHAIRS: Sam Harirforoosh, PharmD, PhD, Associate Professor, Gatton Coll of Pharmacy Arsham Alamian, PhD, MSc, MACE, Assistant Professor, Coll of Public Health, East Tennessee State Univ TARGET AUDIENCE: This Symposium will be useful for scientists, physicians, pharmacists and other health care providers who have an interest in the rising opioid epidemic and/or currently conduct research on opioid abuse, prescribe or dispense opioids or develop strategies for the management of opioid misuse, abuse, dependence or addiction. GOALS AND OBJECTIVES: Following completion of this activity, the learner will be able to: 1. Appraise the current and rising epidemic of opioid abuse and misuse; 2. Analyze the pharmacologic effects of opioids and their side effects; 3. Demonstrate knowledge of the new CDC guideline for prescribing opioids and its use as a clinical pharmacologic approach and alternative for treatment with a focus on buprenorphine and ketamine; 4. Consider pitfalls and strategies in opioid management in medical settings; 5. Illustrate the importance of medical policy and regulations in opioid therapy including risk assessments, urine drug tests and Prescription Drug Monitoring Programs. 1:30 – 1:35 pm Introduction Sam Harirforoosh, PharmD, PhD, Associate Professor, Gatton Coll of Pharmacy and Arsham Alamian, PhD, MSc, MACE, Assistant Professor, Coll of Public Health, East Tennessee State Univ 1:35 – 2:10 pm Epidemiology of Opioid Abuse & Misuse in America Arsham Alamian, PhD, MSc, MACE, Assistant Professor, Coll of Public Health, East Tennessee State Univ 2:10 – 2:45 pm Clinical Pharmacology of Opioids & Their Adverse Effects Sam Harirforoosh, PharmD, PhD, Associate Professor, Gatton Coll of Pharmacy 2:45 – 3:30 pm CDC Guidelines Annotated as a Clinical Pharmacologic Approach & Alternatives for Treatment With a Presentation of Buprenorphine & Ketamine Robert L. Barkin, MBA, PharmD, Clinical Pharmacologist for the Pain Ctrs of Evanston Hosp & Skokie Hosp of Northshore Univ Health System, Dept of Anesthesiology, Professor, Rush Medical Coll, Faculty of Anesthesiology, Family Medicine & Pharmacology 3:30 – 4:00 pm / Break 4:00 – 4:35 pm Difficult Patients, Difficult Doctors, Difficult Drugs: Pitfalls & Strategies in Opioid Management Farshad Ahadian, MD, Clinical Professor, Dept of Anesthesiology, Medical Director, Ctr for Pain Medicine, Univ of California, San Diego 4:35 – 5:10 pm Medical Policy & Regulations When Prescribing Opioid Therapy for Chronic Non-cancer Pain Gregory R. Polston, MD, Clinical Professor of Anesthesia, Dept of Anesthesiology, Associate Medical Director, Ctr for Pain Medicine, Univ of California, San Diego 5:10 – 5:30 pm Panel Discussion ernative Medicine ernative Medicine ng Trends ng Trends Symposia